A commitment to equitable cancer care has driven Icon Group beyond Australian shores to embrace Pan-Asian opportunities. With the incorporation of Singapore Oncology Consultants [SOC] providing an esteemed foundation on which to build a solid regional presence, the Group has officially signed a joint venture with China’s Guizhou Yibai Pharmaceutical [600594:CH]. This partnership will see Icon Group deliver radiation oncology services across China. With five centres established or in development, and a successful capital raising exercise now focused on delivering another 50, this partnership continues to open opportunities to export quality Australian healthcare expertise.
The strength of our people and reputation has also seen a recent agreement with Acurity Health to deliver integrated cancer services in New Zealand in FY 16/17.